Zhu Suhua - Affiliated Jinling Hospital Medical School, Nanjing University

基本信息

浏览量：10

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 38 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy of immunotherapy in patients with oncogene-driven non-small-cell lung cancer: a systematic review and meta-analysis

Jiayan Chen,Wanjun Lu,Mo Chen,Zijing Cai,Ping Zhan,Xin Liu,Suhua Zhu,Mingxiang Ye,Tangfeng Lv,Jiawen Lv,Yong Song,Dong Wang

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2024): 17588359231225036-17588359231225036

引用0浏览0WOS引用

STING Mediates LPS-induced Acute Lung Injury by Regulating Ferroptosis

Yanli Gu,Liting Lv,Jiajia Jin,Xin Hua,Qiuli Xu,Ranpu Wu,Suhua Zhu,Xin Liu,Tangfeng Lv,Yong Song,Fang Zhang

EXPERIMENTAL CELL RESEARCH（2024）

引用0浏览0WOS引用

ALKBH5 Promotes Non-Small Cell Lung Cancer Progression and Susceptibility to Anti-Pd-l1 Therapy by Modulating Interactions Between Tumor and Macrophages

Xin Hua,Qiuli Xu,Ranpu Wu,Wei Sun,Yanli Gu,Suhua Zhu,Xin Liu,Tangfeng Lv,Yong Song

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCHno. 1 (2024)

引用0浏览0WOS引用

STAT3 Drives the Malignant Progression of Low-Grade Gliomas Through Modulating the Expression of STAT1, FOXO1, and MYC

Yan Li, Fanjing Jiang,Suhua Zhu, Hongwei Jia,Changwei Li

FRONTIERS IN MOLECULAR BIOSCIENCES (2024)

引用0浏览0WOS引用

Efficacy and Safety of Anti-Pd-1/pd-l1-based Dual Immunotherapies Versus PD-1/PD-L1 Inhibitor Alone in Patients with Advanced Solid Tumor: a Systematic Review and Meta-Analysis

Yueying Chen,Hedong Han, Jing Cheng,Qinpei Cheng,Suhua Zhu,Ping Zhan,Hongbing Liu,·Yong Song,Tangfeng Lv

Cancer immunology, immunotherapy CIIno. 8 (2024): 155-155

引用0浏览0WOS引用

Identifying Patients Who Benefit More from Perioperative Immunotherapy Combinations for Resectable Non-Small Cell Lung Cancer Based on Clinical and Molecular Characteristics: a Meta-Analysis of Randomized Clinical Trials

Yunchang Meng,Hedong Han,Suhua Zhu,Chuling Li,Huijuan Li,Zhaofeng Wang,Ranpu Wu,Yimin Wang,Qingfeng Zhang, Yanzhuo Gong,Yong Song,Tangfeng Lv,Hongbing Liu

CLINICAL & TRANSLATIONAL ONCOLOGY (2024)

引用0浏览0WOS引用

A Novel Oral TLR7 Agonist Orchestrates Immune Response and Synergizes with PD-L1 Blockade Via Type I IFN Pathway in Lung Cancer

Xueying Zuo, Qinpei Cheng,Zimu Wang,Jiaxin Liu,Wanjun Lu,Guannan Wu,Suhua Zhu,Xin Liu,Tangfeng Lv,Yong Song

INTERNATIONAL IMMUNOPHARMACOLOGY (2024)

引用0浏览0WOS引用

Efficacy of Immunotherapy in Patients with Oncogene-Driven Non-Small-cell Lung Cancer: a Systematic Review and Meta-Analysis

Jiayan Chen,Wanjun Lu,Mo Chen,Zijing Cai,Ping Zhan,Xin Liu,Suhua Zhu,Mingxiang Ye,Tangfeng Lv,Jiawen Lv,Yong Song,Dong Wang

Therapeutic Advances in Medical Oncology (2024)

引用0浏览0引用

c-myc-mediated upregulation of NAT10 facilitates tumor development via cell cycle regulation in non-small cell lung cancer

Zimu Wang,Yicong Huang,Wanjun Lu,Jiaxin Liu,Xinying Li,Suhua Zhu,Hongbing Liu,Yong Song

Med Oncol（2022）

引用4浏览0WOS引用

Effect of Adjuvant Chemotherapy on Survival of Patients With 8th Edition Stage IB Non-Small Cell Lung Cancer

Yangyang Xu,Bing Wan,Suhua Zhu,Tianli Zhang,Jingyuan Xie,Hongbing Liu,Ping Zhan,Tangfeng Lv,Yong Song

FRONTIERS IN ONCOLOGY（2022）

引用7浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn